Table 2.
Tumors detected in the present study
| Tumor | DBE (positive/negative) | Detection rate | Benign/malignant | Duodenum /jejunum/ileum |
| Adenocarcinoma | 23 (22/1) | 29.50% | 0/23 | 6/16/1 |
| GIST | 19 (16/3) | 24.40% | 6/13 | 3/12/4 |
| Lymphoma | 12 (9/3) | 15.40% | 0/12 | 1/6/5 |
| Lipoma | 8 (7/1) | 10.30% | 8/0 | 0/8/0 |
| Metastatic carcinoma | 8 (8/0) | 10.30% | 0/8 | 3/2/3 |
| Hamartoma | 2 (2/0) | 2.60% | 2/0 | 1/0/1 |
| Others1 | 6 (3/3) | 7.70% | 4/2 | 2/3/1 |
| Total | 78 (67/11) | 100% | 20/58 | 16/47/15 |
1
1 duodenal Brunner’s adenoma, 1 ileal hemangioma, 1 duodenal gangliocytic paraganglioma, 1 jejunal mesangial fibrosarcoma,1 jejunal inflammatory myofibroblastic tumor, 1 jejunal serosa fibromatosis. DBE: Double-balloon enteroscopy; GIST: Gastrointestinal stromal tumor.